Navigation Links
Midwest Healthcare Startups Raise $996 Million in 2012
Date:1/7/2013

CLEVELAND, Jan. 7, 2013 /PRNewswire/ -- Midwest healthcare companies attracted $996 million in new investments across 182 companies in 2012 according to the BioEnterprise Midwest Healthcare Venture Investment Report.  The total dollars attracted is up by twenty-three percent from 2011. Ohio ($292 million), Minnesota ($165 million), and Illinois ($146 million) led Midwestern states in attracting investment dollars; Cleveland, Minneapolis, and Chicago were the leaders among Midwest regions.

(Logo:  http://photos.prnewswire.com/prnh/20101028/DC90488LOGO )

"Investment activity in Midwest healthcare deals continues its upward trend, outperforming previous years' activity for 3 years in a row.
As with the rest of the country, Midwest healthcare investing fell dramatically in 2009 after strong years in 2007 and 2008, but it appears investors are again optimistic about Midwest deals. 2013 should be an interesting year to watch," said Aram Nerpouni, Interim President of BioEnterprise, the Cleveland biomedical accelerator.

By sector, the 2012 equity funding was allocated as follows:

  • Medical device companies:  $309 million (32%)
  • Healthcare IT and service companies: $177 million (18%)
  • Biopharmaceutical companies: $487 million (50%)
  • "The Midwest typically sees more medical device companies than either healthcare IT or biopharmaceutical; however, biotech saw the largest influx of dollars in 2012 as investors continue to focus on  later stage biotech opportunities," said Nerpouni.  "Investment activity in Midwest healthcare IT remains robust as investors are drawn by payers and providers searching for applications to improve patient outcomes and efficiencies."

    The Midwest Healthcare Venture Investment Report includes all reported numbers and regionally collected data. For complete state and region results across the Midwest, see the attached table. To view additional data about Midwest healthcare business activity visit www.bioenterprise.com/Reports/.

    Table:  Midwest Healthcare Venture Investment (By State)State20122011201020092008$ Millions# of Cos.$ Millions# of Cos.$ Millions# of Cos.$ Millions# of Cos.$ Millions# of Cos.Illinois146.2

    10

    44.2

    9

    160.9

    11

    38.9

    8

    97.3

    13Indiana64.7

    11

    14.1

    9

    25.05

    16

    76.3

    14

    75.4

    7Iowa-

    -

    -

    -

    7.3

    1

    36.8

    3

    4.0

    1Kansas-

    -

    18.5

    2

    14.5

    13

    4.3

    5

    16.9

    9Kentucky33.8

    4

    11.5

    7

    11.4

    4

    97.3

    7

    19.2

    6Michigan107.1

    16

    30.8

    16

    76.3

    12

    102.2

    14

    105.0

    12Minnesota164.7

    17

    223.3

    24

    138.7

    20

    199.0

    23

    318.9

    22Missouri57.2

    6

    168.7

    9

    19.9

    9

    65.8

    8

    50.2

    11Ohio291.7

    70

    177.8

    67

    147.2

    47

    105.4

    40

    189.1

    43Western Pennsylvania 81.5

    37

    67.0

    25

    86.2

    20

    37.8

    24

    126.2

    33Wisconsin48.8

    11

    53.8

    9

    51.3

    9

    16.2

    10

    48.5

    8Total995.7182809.7177738.8162780.01561,050.7165Table:  Midwest Healthcare Venture Investment (By Region)*Region20122011201020092008$ Millions# of Cos.$  Millions# of Cos.$  Millions# of Cos.$ Millions# of Cos.$
    Millions# of Cos.Chicago146.2

    9

    44.2

    9

    160.9

    11

    38.9

    8

    97.3

    13Indianapolis64.7

    10

    11.5

    7

    18.5

    9

    41.2

    9

    73.0

    6Louisville7.9

    3

    11.4

    6

    11.4

    4

    2.5

    4

    13.4

    3Detroit-Ann Arbor107.1

    15

    23.0

    10

    46.5

    8

    68.8

    7

    89.0

    8SW Michigan-

    -

    7.8

    6

    29.8

    4

    14.5

    5

    16.0

    2Minneapolis162.4

    15

    223.3

    24

    138.7

    20

    199.0

    23

    318.9

    22St. Louis57.2

    6

    112.7

    8

    18.9

    9

    27.8

    7

    47.2

    10Kansas City*-

    -

    18.5

    2

    15.4

    13

    42.3

    6

    19.9

    10Cincinnati*77.3

    12

    37.3

    6

    8.5

    4

    121.2

    8

    19.2

    2Cleveland226.5

    43

    124.7

    40

    135.1

    33

    66.3

    21

    163.5

    31Columbus13.3

    11

    15.1

    19

    3.1

    5

    12.4

    13

    6.4

    10Pittsburgh81.5

    37

    67.0

    25

    86.2

    20

    37.8

    24

    126.2

    33Wisconsin48.8

    11

    53.8

    9

    51.3

    9

    16.2

    10

    48.5

    8* Border MSAs such as Kansas City and Cincinnati include deals from both states in those geographies; deals are aggregated into state totals based on the MSA's principal state

    **Regions' totals do not equal states as not all areas are included in list of regions

    Sources: Compiled by BioEnterprise from Venture Wire, Private Equity Week, Wall Street Journal, Venture Source, SEC Filings, company press releases, www.biospace.com, and Midwest bioscience organizations and institutions.

    About BioEnterpriseBioEnterprise is a business formation, recruitment, and acceleration effort designed to support the growth of bioscience companies. Located in Cleveland, BioEnterprise provides management counsel and support services to healthcare companies. BioEnterprise partners are Case Western Reserve University, Cleveland Clinic, University Hospitals, Summa Health System, and the Austen BioInnovation Institute in Akron. Additional technology partners include the NASA Glenn Research Center, Cleveland State University, NorTech, and BioOhio.

    The initiative comprises the collective activities of BioEnterprise and its partners' commercialization offices:  the Case Office of Technology Transfer, Cleveland Clinic Innovations, University Hospitals Case Medical Center - Center for Clinical Research and Summa Enterprise Group.  The combined efforts of these groups has created, recruited, and accelerated more than 130 companies in ten years.


    '/>"/>
    SOURCE BioEnterprise Corporation
    Copyright©2012 PR Newswire.
    All rights reserved

    Related biology technology :

    1. Genetics Policy Institute (GPI) Collaborates on Second Midwest Conference on Stem Cell Biology and Therapy, Oct. 5-7 at Oakland University
    2. BioSpace Spotlights the growing Midwest Life Science Community
    3. Karmanos Cancer Center first in Midwest to offer latest Molecular Breast Imaging
    4. Sequenom Announces Participation at the Lazard Capital Markets 8th Annual Healthcare Conference
    5. Bayer HealthCares Cotavance® Drug Eluting Balloon With Paccocath® Technology Reduced Five-Year Target Lesion Revascularization Rates by 59 Percent in PAD Patients Compared to Those Treated With Uncoated Balloon
    6. Organovo to Present at Lazard Capital Markets 8th Annual Healthcare Conference
    7. Pharmasset to Present at the Lazard Capital Markets Healthcare Conference
    8. Sequenom Announces Participation at the 23rd Annual Piper Jaffray Healthcare Conference
    9. SuperNova Diagnostics® to Present at the 23rd Annual Piper Jaffray Healthcare Conference in New York City
    10. diaDexus, Inc. to Present at the Canaccord Genuity Healthcare Conference
    11. ViroPharma to Participate in Two December Healthcare Investor Conferences
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:2/5/2016)... -- ATCC, the premier global biological materials resource and ... life science researchers that are working to address the ... CDC website . --> CDC website ... single-stranded RNA virus of the Flaviviridae family, genus Flavivirus, ... Viruses. Zika virus is transmitted to humans primarily through ...
    (Date:2/5/2016)... , February 5, 2016 Amarantus ... biotechnology company focused on developing products for Regenerative Medicine, ... Rare Pediatric Disease Designation (RPDD) from the US Food ... with MANF. MANF was previously granted orphan drug designation ... --> Amarantus BioScience Holdings, Inc. (OTCQB: ...
    (Date:2/4/2016)... 2016 - New FDA action date of ... FDA action date of July 22, 2016   ... 22, 2016   - Lifitegrast has ... indicated for the treatment of signs and symptoms of dry eye ... potential to be the only product approved in the U.S. in the past decade indicated ...
    (Date:2/4/2016)... Falls Church, VA (PRWEB) , ... ... ... a first-year cybersecurity conference presented by Bloomsburg University’s Digital Forensics Club, takes ... Bloomsburg, PA. The two-day event features 20+ speakers and activities such as ...
    Breaking Biology Technology:
    (Date:1/25/2016)... -- Glencoe Software, the world-leading supplier of image data management ... the data management solution OMERO Plus for the newly ... Photo - http://photos.prnewswire.com/prnh/20160125/325328LOGO ... Phenotypic analysis measures the characteristics and behavior of cells, ... such as health and disease, the presence or absence ...
    (Date:1/20/2016)... , Jan. 20, 2016 A market that ... directly benefit from the explosion in genomics knowledge. Learn ... Sound Research. A range of dynamic trends are pushing ... - personalized medicine - pharmacogenomics - pathogen evolution - ... large markets - greater understanding of the role of ...
    (Date:1/15/2016)... , Jan. 15, 2016 Recent publicized breaches ... to find new ways to ensure data security and ... iOS and Android that ties a ... transforming it into a hardware authorization token. Customer service ... their fingerprint on their KodeKey enabled device to verify ...
    Breaking Biology News(10 mins):